Stockscreener 앱 받기
16.05
3.55%
0.55
시간 외 거래:
16.48
0.43
+2.68%
전일 마감가:
$15.50
열려 있는:
$15.75
하루 거래량:
303.93K
Relative Volume:
6.62
시가총액:
$851.10M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$15.44
$16.24
1주일 범위
$14.85
$19.17
52주 변동 폭
$14.85
$19.17
Seaport Therapeutics Inc Stock (SPTX) Company Profile
Compare SPTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPTX
Seaport Therapeutics Inc
|
16.05 | 821.93M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.87B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
714.89 | 74.34B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
782.17 | 48.96B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.05 | 39.51B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
312.12 | 32.89B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seaport Therapeutics Inc 주식(SPTX)의 최신 뉴스
What is the current Price Target and Forecast for Seaport Therapeutics, Inc (SPTX) - Zacks Investment Research
IPO Tracker 2026: Odyssey launches upsized $279M IPO, Seaport docks on Nasdaq - BioSpace
Biotech firm Odyssey raises $279 million in upsized US IPO - 93.3 The Drive
Seaport Therapeutics Stock Price Today | NASDAQ: SPTX Live - Investing.com
The Readout LOUD Podcast Discusses Seaport Therapeutics’ IPO and Obesity Pill Competition on May 7, 2026 - geneonline.com
Seaport, Hemab price upsized IPOs, eyeing $550M in proceeds - MSN
Seaport Therapeutics (SPTX) Stock Analysis Report | Financials & Insights - Benzinga
Seaport Therapeutics set for Nasdaq debut after raising $255 million in IPO - MSN
Seaport Therapeutics (SPTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Hemab, Seaport surge as clinical-stage biotechs make trading debuts - MSN
SPTX News Today | Why did Seaport Therapeutics stock go up today? - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Seaport Therapeutics (SPTX) Stock Price, News & Analysis - MarketBeat
SPTX | Seaport Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
SPTX | Seaport Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News - Quiver Quantitative
Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Seaport Therapeutics, Inc (SPTX) Stock Price Today & Analysis - Gotrade
SPTX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Number of employees of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Some Extraordinary Numbers From Earnings Season - Bloomberg
SPTX Technical Analysis & Stock Price Forecast - Intellectia AI
Seaport Therapeutics (SPTX) Stock Chart and Price History 2026 - MarketBeat
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – BOATS:SPTX - TradingView
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move - Yahoo Finance
Seaport and Hemab Therapeutics Launch IPOs, Raising $556 Million - geneonline.com
Seaport Therapeutics, Inc.(NasdaqGS: SPTX) added to NASDAQ Composite Index - marketscreener.com
Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years - MedCity News
Seaport Therapeutics Set For Nasdaq Debut After Raising $255 Million In IPO - Yahoo Finance
SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart - MEXC Exchange
SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
SPTX Technical Analysis | Trend, Signals & Chart Patterns | SEAPORT THERAPEUTICS INC (NASDAQ:SPTX) - ChartMill
Psychiatry drugmaker Seaport seeks $212.4 million in US IPO - MSN
Seaport Therapeutics, Inc. Revenue Breakdown – NASDAQ:SPTX - TradingView
Latham & Watkins Advises on Seaport Therapeutics’ Upsized US$254.9 Million Initial Public Offering - Legal Desire
Enterprise value of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Diluted net income available to common stockholders of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Net debt of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Price to book ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Non-operating income (total) of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
EBITDA margin % of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Cash from financing activities of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
EBITDA per share of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Free cash flow of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Long term debt to total assets ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Total liabilities of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Price to sales ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Total debt of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Debt to assets ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Quick ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Seaport Therapeutics Inc (SPTX) 재무 분석
Seaport Therapeutics Inc (SPTX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
11.97%
3.48%
자본화:
|
볼륨(24시간):